Event Date: 11/14/2024

Unlocking Longevity: Innovations in Brain Health & Alzheimer’s Prevention with Pioneering Neurologist Dr. Richard S. Isaacson

Would you like to share with close friends or colleagues?

Location: Virtual

Date: November 14, 2024

Time: 12:00 PM – 1:00 PM CT

10a PT | 11a MT | 1p ET

Join us for an exclusive conversation with pioneering neurologist Dr. Richard S. Isaacson as we delve into the forefront of longevity science and Alzheimer’s prevention during National Alzheimer’s Disease Awareness Month. Alzheimer’s disease is the most common cause of dementia worldwide, accounting for 60-70% of cases, with approximately 50 million people affected globally, highlighting its significant impact on individuals and families.

We welcome Dr. Isaacson, a neurologist and expert in dementia prevention at Atria, to guide us through the latest breakthroughs and advancements in brain health, longevity science, and Alzheimer’s prevention. Explore what is biologically achievable now and in the future as Dr. Isaacson shares innovative strategies and research findings that are shaping brain health and aging. Gain actionable insights on enhancing cognitive health, mitigating the risk of Alzheimer’s, and extending your longevity.

Atria is a state-of-the-art precision-based health care practice with locations in New York and Palm Beach. With a team of world-renowned doctors and experts, Atria uses cutting-edge technology and groundbreaking science to deliver personalized, proactive, and preventive care to its members and their families. Whether at their Institutes, in the comfort of your home, or anywhere in the world, Atria’s mission is to make healthspan and lifespan equal for everyone by pushing the boundaries of science and medicine.

About Dr. Richard Isaacson

Dr. Richard S. Isaacson is a pioneering neurologist with a focus on the treatement and prevention of Alzheimer's disease. He is the Founder and Former Director of the Alzheimer's Prevention Clinic, a first-of-its-kind in the world, at Weill Cornell Medicine & New York Presbyterian, where he was also Assistant Dean of Faculty Development and Associate Professor of Neurology.

Dr. Isaacson remains on faculty as an Adjunct Associate Professor of Neurology at Weill Cornell and comes to Atria from Florida Atlantic University Schmidt College of Medicine, were he served as Director of the Center of Brain Health.

On his decision to join Atria, he says he was drawn to work in a medical environment where being forward-thinking is encouraged rather than frowned upon. "This approach often goes against the traditional grain in medical care, which is typically informed by practice guidelines that are often outdated soon after being published," he says. "At Atria, we have the time and personnel to have multidisciplinary care discussions about each and every patient and family we see."

Dr. Isaacson began his academic career in an accelerated six-year program at the Unversity of Missouri-Kansas City School of Medicine, where he earned his Bachelor of Liberal Arts at age 19 and his medical degree at the age of 23. He cites a family history of Alzheimer's - as well as his older brother, also a neurologist - as early inspiration for his focus on the disease.

Featuring

Dr. Richard Isaacson

Dr. Richard Isaacson

Neurologist & Director of the Atria Precision Prevention Program

More Recent Events You May Like...

SaraMednick Thumbnail 725x525

04/29/2022 - Restore Your Energy & Recharge Your Life with Cognitive Neuroscientist Dr. Sara Mednick

Norma Kamali

01/19/2021 - Norma Kamali’s Guide to Aging with Power & Purpose

2022.01.13 Jim Karas 725x525

01/13/2022 - Inside the Life of a D-1 Athlete:A Dad and Daughter’s Guide to Survival

We use cookies to improve your web experience, analyze site usage, and deliver personalized content to you. Some cookies are essential to site functionality, others are optional and help us see how the site is used or allow us to better service you.  By clicking “Accept” you are accepting all cookies. To better understand how cookies are used by us or to opt-out, visit Terms of Use.